2013 Prior Authorization Drug Requirements - CCHP
2013 Prior Authorization Drug Requirements - CCHP
2013 Prior Authorization Drug Requirements - CCHP
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>CCHP</strong> Senior Select Program (HMO SNP)<br />
<strong>2013</strong> <strong>Prior</strong> <strong>Authorization</strong> <strong>Drug</strong> <strong>Requirements</strong><br />
Last Updated 04/01/<strong>2013</strong><br />
FORMULARY<br />
DRUG<br />
BRAND NAME<br />
generic name<br />
DRUG<br />
TIER<br />
LEVEL<br />
COVERED<br />
USES<br />
Arthritis.<br />
Still’s disease.<br />
Psoriatic<br />
arthritis.<br />
Ulcerative<br />
colitis. Behcet<br />
syndrome<br />
uveitis. Celiac<br />
sprue.<br />
Erythrodermic<br />
psoriasis.<br />
Giant cell<br />
arteritis. Graft<br />
versus host<br />
disease.<br />
Hidradenitis<br />
suppurativa.<br />
Juvenile<br />
idiopathic<br />
arthritis.<br />
Pustular<br />
psoriasis.<br />
Pyoderma<br />
gangrenosum.<br />
Sarcoidosis.<br />
Uveitis.<br />
EXCLUSION<br />
CRITERIA<br />
REQUIRED<br />
MEDICAL<br />
INFORMATION<br />
maintenance of<br />
remission (MR). Got 3<br />
infliximab (IFB) doses<br />
and responded, or tried<br />
azathioprine (AZA), 6-<br />
mercaptopurine (6MP),<br />
MTX, adalimumab, or<br />
certolizumab pegol.<br />
Fistulizing CD (FCD)<br />
for IR, approve. FCD for<br />
MR. Got 3 doses of IFB<br />
and responded. Plaque<br />
psoriasis (PP). A<br />
minimum body surface<br />
area (BSA) of 5% or<br />
more, exceptions for less<br />
than 5% BSA if PP of<br />
palms, soles, head/neck,<br />
nails, intertriginous areas<br />
or genitalia or<br />
inadequate response to<br />
2-mo trial of topical<br />
therapy (tx) OR<br />
localized phototx<br />
(ultraviolet B [UVB] or<br />
oral methoxsalen plus<br />
AGE<br />
RESTRICTION<br />
PRESCRIBER<br />
RESTRICTION<br />
COVERAGE<br />
DURATION<br />
OTHER<br />
CRITERIA<br />
of systemic CS,<br />
6-MP, AZA,<br />
CSA or<br />
tacrolimus.<br />
Uveitis.Tried<br />
periocular/intrao<br />
cular CS,<br />
systemic CS,<br />
immunosuppres<br />
sant (eg, MTX,<br />
mycophenolate<br />
mofetil, CSA,<br />
AZA,<br />
cyclophosphami<br />
de), etanercept,<br />
adalimumab.<br />
Pyoderma<br />
gangrenosum<br />
(PG).Tried 1<br />
systemic tx (eg,<br />
systemic CS,<br />
immunosuppres<br />
sant (eg, AZA,<br />
6MP, CSA,<br />
cyclophosphami<br />
de,<br />
<strong>CCHP</strong> Senior Select Program (HMO SNP) is a Coordinated Care plan with a Medicare contract and a contract with the California Medicaid program.<br />
H0571_<strong>2013</strong>_142_FINAL_2 Approved 11282012<br />
188